A phase II exploratory study (NCT06208826) on maintenance immunotherapy in patients with resectable locally advanced head and neck cancer who achieved MPR after neoadjuvant immunotherapy combined with chemotherapy.

Authors: Hongling Wang, Xudong Wang, Yanwei Li, Peiguo Wang, Ximei Zhang, Yi Pan, Jianyu Xiao, Ruifen Cheng

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18083

Source: Full article

e18083